drugset / Trial / NCT01983735
Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of present study is to evaluate the efficacy and safety of two dose combination of Telmisartan/S-Amlodipine (80/2.5mg and 80/5mg) compared with S-Amlodipine monotherapy (2.5mg and 5mg) in patients with Stage 2 hypertension.
Timeline
- Start
- 2014-01
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | S-amlodipine | Unknown | 2.5 mg | — |
| Comparator | S-amlodipine | Unknown | 5 mg | — |
| Subject | Telmisartan | Other / unclassified | 80 mg | — |